De Stefano, Valerio
 Distribuzione geografica
Continente #
NA - Nord America 5.769
EU - Europa 5.714
AS - Asia 2.353
SA - Sud America 372
AF - Africa 59
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 7
Totale 14.295
Nazione #
US - Stati Uniti d'America 5.681
DE - Germania 1.500
SE - Svezia 1.127
SG - Singapore 935
IT - Italia 884
CN - Cina 814
UA - Ucraina 474
IE - Irlanda 358
FR - Francia 320
BR - Brasile 319
GB - Regno Unito 225
ID - Indonesia 218
PL - Polonia 206
FI - Finlandia 203
IN - India 171
RU - Federazione Russa 151
CA - Canada 53
AT - Austria 52
BE - Belgio 39
NL - Olanda 39
HK - Hong Kong 36
TR - Turchia 36
AR - Argentina 30
JP - Giappone 29
ES - Italia 28
CI - Costa d'Avorio 27
MX - Messico 26
AU - Australia 19
IR - Iran 19
CZ - Repubblica Ceca 18
CH - Svizzera 14
RO - Romania 14
VN - Vietnam 13
LT - Lituania 11
MA - Marocco 10
IQ - Iraq 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
IL - Israele 7
CL - Cile 6
HU - Ungheria 6
KR - Corea 6
LV - Lettonia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BD - Bangladesh 5
EE - Estonia 5
GR - Grecia 5
NO - Norvegia 5
PE - Perù 5
PT - Portogallo 5
TW - Taiwan 5
AL - Albania 4
DZ - Algeria 4
HR - Croazia 4
KG - Kirghizistan 4
MD - Moldavia 4
PA - Panama 4
SA - Arabia Saudita 4
TN - Tunisia 4
ZA - Sudafrica 4
AM - Armenia 3
BG - Bulgaria 3
JO - Giordania 3
KE - Kenya 3
MY - Malesia 3
NG - Nigeria 3
TH - Thailandia 3
BO - Bolivia 2
CO - Colombia 2
DK - Danimarca 2
EC - Ecuador 2
EU - Europa 2
LA - Repubblica Popolare Democratica del Laos 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PK - Pakistan 2
PS - Palestinian Territory 2
PY - Paraguay 2
UY - Uruguay 2
UZ - Uzbekistan 2
VE - Venezuela 2
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
JM - Giamaica 1
KW - Kuwait 1
KZ - Kazakistan 1
LI - Liechtenstein 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NI - Nicaragua 1
OM - Oman 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TG - Togo 1
Totale 14.295
Città #
Chandler 1.169
Singapore 525
Ashburn 462
Dublin 352
San Mateo 277
Jacksonville 276
Jakarta 216
Wilmington 211
Nanjing 187
Warsaw 179
Ann Arbor 161
Cattolica 160
Munich 159
Boston 147
Fairfield 147
Dearborn 143
Milan 140
Rome 136
New York 121
Woodbridge 121
Houston 108
Moscow 101
Princeton 100
Redmond 95
Beijing 92
Los Angeles 92
Marseille 91
Lawrence 90
Seattle 85
Helsinki 82
Redwood City 75
Nanchang 68
Hyderabad 62
Nürnberg 49
Chicago 47
Bremen 43
Boardman 38
The Dalles 37
Norwalk 36
Brussels 35
Hebei 35
Frankfurt am Main 34
Hong Kong 34
Kunming 33
Mountain View 33
Nuremberg 32
Cambridge 31
University Park 30
Hangzhou 28
São Paulo 28
Zhengzhou 28
Abidjan 27
Shenyang 27
Detroit 26
Düsseldorf 26
Florence 26
Vienna 26
Jiaxing 25
Lancaster 25
Leawood 25
London 25
Pune 25
Izmir 24
Tianjin 24
Kraków 23
Toronto 23
Paris 22
Changsha 21
Guangzhou 21
Washington 19
Casalecchio di Reno 17
Federal 16
Mexico 16
Shanghai 16
Tobarra 16
Wayne 16
Brno 14
Rio de Janeiro 13
Belo Horizonte 12
San Diego 12
Andover 11
Falls Church 11
Falkenstein 10
Hefei 10
Portsmouth 10
San Francisco 10
Clearwater 9
Jinan 9
Lanzhou 9
Naples 9
Pordenone 9
Augusta 8
Busto Arsizio 8
Ottawa 8
Phoenix 8
Santa Clara 8
Simi Valley 8
Baku 7
Lauterbourg 7
Monmouth Junction 7
Totale 7.845
Nome #
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 291
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 275
Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients. 269
Association of congenital protein C deficiency and latent myeloproliferative disease as cause of splanchnic venous thrombosis in a 34-year-old woman 233
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 212
Haemostatic alterations induced by treatment with asparaginases and clinical consequences 197
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 179
Risk factor and etiology analysis of ischemic stroke in young adult patients 148
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 140
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 137
Safety of granulocyte-colony-stimulating factor in acute myocardial infarction (the Rigenera study). 136
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 135
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 133
Health Technology Assessment of genetic testing for susceptibility to Venous Thromboembolism in Italy 131
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment 129
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 128
A Case of Heparin Allergy With Good Tolerability to Fondaparinux During Pregnancy 127
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 125
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 124
Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect 123
Fondaparinux in pregnancy: Could it be a safe option? A review of the literature. 121
Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms 120
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 116
A real-time integrated framework to support clinical decision making for covid-19 patients 114
Bisphosphonate therapy in multiple myeloma in preventing vertebral collapses: preliminary report 113
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments 112
Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms 111
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms 111
Factor V deficiency in pregnancy complicated by Rh immunization and placenta previa. A case report and review of the literature 110
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 110
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 109
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 108
Allogeneic cord blood transfusions prevent fetal haemoglobin depletion in preterm neonates. Results of the CB-TrIP study 107
Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms 103
Venous thromboembolism in multiple myeloma 102
A Case of Heparin Allergy With Good Tolerability to Fondaparinux During Pregnancy. 102
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis 101
JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis 100
Autoimmune hemolytic anemia with gel-based immunohematology tests: neural network analysis 98
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 98
Postpartum hemorrhage 97
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 97
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment 97
The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia 96
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 96
Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease 94
Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluation 94
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 94
A STARD-compliant prediction model for diagnosing thrombotic microangiopathies 93
Prognostic Factors Associated With Progression of Smoldering Multiple Myeloma to Symptomatic Form 92
Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis) 92
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 86
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment 85
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 84
Factor V deficiency in pregnancy complicated by Rh immunization and placenta previa. A case report and review of the literature 83
Ineherited Thrombophilia: treatment during pregnancy 83
High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with Vitamin K antagonists 82
Inherited thrombophilia: treatment during pregnancy. 81
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B(2) assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 81
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 81
The Effects of Granulocyte Colony-Stimulating Factor in Patients with a Large Anterior Wall Acute Myocardial Infarction to Prevent Left Ventricular Remodeling: A 10-Year Follow-Up of the RIGENERA Study 77
Improved Detection of Minimal Residual Disease by 11C-Methionine PET/CT in a Young Patient With Unusual Extramedullary Presentation of Recurrent Multiple Myeloma 76
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 76
Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European Leukemia Net study 75
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 75
IgD multiple myeloma a descriptive report of 17 cases: survival and response to therapy 74
Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia 74
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 74
Primary plasma cell leukemia: a retrospective multicenter study of 73 patients 72
Improved Detection of Minimal Residual Disease by 11C-Methionine PET/CT in a Young Patient with Unusual Extramedullary Presentation of Recurrent Multiple Myeloma 72
Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study 72
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 72
In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband 71
Platelet indices and glucose control in type 1 and type 2 diabetes mellitus: A case-control study 71
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 71
Evaluation of the prevalence of severe hyperhomocysteinemia in adult patients with thrombosis who underwent screening for thrombophilia 70
Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups 69
Myeloid sarcoma with megakaryoblastic differentiation mimicking a sellar tumor 69
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 69
The interaction between small intestinal bacterial overgrowth and warfarin treatment 68
Obstetric complications and pregnancy-related venous thromboembolism: The effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation 68
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 68
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN 67
Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia 65
Pre-Exposure to Defibrotide Prevents Endothelial Cell Activation by Lipopolysaccharide: An Ingenuity Pathway Analysis 65
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 64
Associations of coagulation factor V Leiden and prothrombin G20210A mutations with Budd-Chiari syndrome and portal vein thrombosis: a systematic review and meta-analysis 63
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 62
Nutritional status and quality of life in adults undergoing allogeneic hematopoietic stem cell transplantation 62
Splanchnic vein thrombosis in myeloproliferative neoplasms: Risk factors for recurrences in a cohort of 181 patients 61
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 61
Remission of acquired von Willebrand syndrome in a patient with chronic lymphocytic leukemia treated with venetoclax 61
Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers 61
Associations of antiphospholipid antibodies with splanchnic vein thrombosis: a systematic review with meta-analysis 60
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 60
Structural analysis of protein Z gene variants in patients with foetal losses 59
Italian daily platelet transfusion practice for haematological patients undergoing high dose chemotherapy with or without stem cell transplantation: A survey by the GIMEMA Haemostasis and Thrombosis Working Party 59
Ultrasound-Doppler diagnosis of Budd-Chiari syndrome 58
Abdominal thromboses of splanchnic, renal and ovarian veins 58
Management of venous thromboembolism in myeloproliferative neoplasms 58
Totale 10.013
Categoria #
all - tutte 76.140
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.140


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020362 0 0 0 0 0 0 0 0 0 0 223 139
2020/20211.241 56 135 32 132 156 75 137 29 145 47 271 26
2021/20221.674 130 103 25 76 100 29 24 259 81 108 320 419
2022/20233.370 509 476 294 484 206 378 178 226 368 91 110 50
2023/20241.742 74 506 57 78 77 234 107 96 32 60 188 233
2024/20252.604 98 135 275 122 337 114 217 215 638 392 61 0
Totale 14.596